✦ LIBER ✦

A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease

✍ Scribed by S. A. Bartram; R. T. Peaston; D. J. Rawlings; R. M. Francis; N. P. Thompson

Book ID: 108603468
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 102 KB
Volume: 18
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2003.01794.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of high-dose vitamin D on bon

The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial

✍ G. Grimnes; R. Joakimsen; Y. Figenschau; P. A. Torjesen; B. Almås; R. Jorde 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 320 KB

Long-term dalteparin in pregnancy not as

Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

✍ M. A. RODGER; S. R. KAHN; A. CRANNEY; A. HODSMAN; M. J. KOVACS; A. M. CLEMENT; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

Multinational, Placebo-Controlled, Rando

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

✍ H. A. P. Pols; D. Felsenberg; D. A. Hanley; J. Štepán; M. Muñoz-Torres; T. J. Wi 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 86 KB

The presence of a polymorphism at the tr

The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal mexican-American women

✍ Coleman Gross; T. Ross Eccleshall; Peter J. Malloy; Marie Luz Villa; Robert Marc 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 531 KB

We examined the association of bone mineral density (BMD) with a polymorphism in the gene encoding the vitamin D receptor (VOR) that causes a change in the predicted protein sequence. The polymorphism results from a C-to-T transition and creates an initiation codon (ATG) three codons proximal to a d

The vitamin D analogue 2MD increases bon

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial

✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 215 KB 👁 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1α,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in